Western University

Scholarship@Western
Paediatrics Publications

Paediatrics Department

2-25-2014

Dual effect of CTCF loss on neuroprogenitor differentiation and
survival
L. Ashley Watson
Western University

Xu Wang
Western University

Adrienne Elbert
Western University

Kristin D. Kernohan
Western University

Niels Galjart
Erasmus MC

See next page for additional authors

Follow this and additional works at: https://ir.lib.uwo.ca/paedpub

Citation of this paper:
Watson, L. Ashley; Wang, Xu; Elbert, Adrienne; Kernohan, Kristin D.; Galjart, Niels; and Bérubé, Nathalie G.,
"Dual effect of CTCF loss on neuroprogenitor differentiation and survival" (2014). Paediatrics
Publications. 725.
https://ir.lib.uwo.ca/paedpub/725

Authors
L. Ashley Watson, Xu Wang, Adrienne Elbert, Kristin D. Kernohan, Niels Galjart, and Nathalie G. Bérubé

This article is available at Scholarship@Western: https://ir.lib.uwo.ca/paedpub/725

2860 • The Journal of Neuroscience, February 19, 2014 • 34(8):2860 –2870

Cellular/Molecular

Dual Effect of CTCF Loss on Neuroprogenitor Differentiation
and Survival
L. Ashley Watson,1,2 Xu Wang,1,2 Adrienne Elbert,1,2 Kristin D. Kernohan,1,2 Niels Galjart,3 and Nathalie G. Bérubé1,2
1

Departments of Paediatrics and Biochemistry, The University of Western Ontario and 2Children’s Health Research Institute, London, Ontario N6C 2V5,
Canada and 3Medical Genetics Centre Department of Cell Biology and Genetics, Erasmus University, 3000 CA, Rotterdam, The Netherlands

An increasing number of proteins involved in genome organization have been implicated in neurodevelopmental disorders, highlighting
the importance of chromatin architecture in the developing CNS. The CCCTC-binding factor (CTCF) is a zinc finger DNA binding protein
involved in higher-order chromatin organization, and mutations in the human CTCF gene cause an intellectual disability syndrome
associated with microcephaly. However, information on CTCF function in vivo in the developing brain is lacking. To address this gap, we
conditionally inactivated the Ctcf gene at early stages of mouse brain development. Cre-mediated Ctcf deletion in the telencephalon and
anterior retina at embryonic day 8.5 triggered upregulation of the p53 effector PUMA (p53 upregulated modulator of apoptosis), resulting
in massive apoptosis and profound ablation of telencephalic structures. Inactivation of Ctcf several days later at E11 also resulted in
PUMA upregulation and increased apoptotic cell death, and the Ctcf-null forebrain was hypocellular and disorganized at birth. Although
deletion of both Ctcf and Puma in the embryonic brain efficiently rescued Ctcf-null progenitor cell apoptosis, it failed to improve neonatal
hypocellularity due to decreased proliferative capacity of rescued apical and outer radial glia progenitor cells. This was exacerbated by an
independent effect of CTCF loss that resulted in depletion of the progenitor pool due to premature neurogenesis earlier in development.
Our findings demonstrate that CTCF activities are required for two distinct events in early cortex formation: first, to correctly regulate the
balance between neuroprogenitor cell proliferation and differentiation, and second, for the survival of neuroprogenitor cells, providing new
clues regarding the contributions of CTCF in microcephaly/intellectual disability syndrome pathologies.
Key words: apoptosis; CTCF; differentiation; mouse model; neurogenesis; Puma

Introduction
CTCF is a multifunctional DNA binding protein that regulates
higher-order chromatin structure to influence transcriptional
regulation, genomic imprinting, X chromosome inactivation,
and chromatin insulation (Holwerda and de Laat, 2013). It binds
to a variety of highly divergent target sequences throughout the
genome using a combination of its 11 zinc finger motifs (Nakahashi et al., 2013). CTCF partners with a number of chromatinrelated proteins such as the cohesin complex (Parelho et al., 2008;
Wendt et al., 2008), nucleophosmin, and CTCF itself (Yusufzai
and Felsenfeld, 2004; Yusufzai et al., 2004). These interactions
may allow CTCF sites to contact one another and/or to be tethered to subnuclear domains. CTCF-mediated chromatin interactions detected by Chromatin interaction analysis by paired-end
tag sequencing (ChIA-PET) correlate with ⬃10% of all CTCF
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binding sites (CBSs), however, indicating that CTCF likely plays
additional roles within the cell (Handoko et al., 2011).
De novo mutations in CTCF have been identified previously in
patients with varying degrees of intellectual disability and microcephaly (Gregor et al., 2013), highlighting the importance of
chromatin organization for the normal development and function of the CNS. Whereas CTCF function has been studied extensively in cell culture systems, its function in an in vivo context
remains to be completely resolved (Ohlsson et al., 2010). Ubiquitous deletion of CTCF in the mouse leads to lethality before
embryonic day 3.5 (E3.5), suggesting that it is essential for early
developmental processes (Fedoriw et al., 2004; Heath et al., 2008;
Moore et al., 2012). Conditional deletion of Ctcf in specific tissues
causes either reduced proliferation or apoptotic cell death, depending on the tissue targeted for Cre recombination. For example, deletion of Ctcf in thymocytes resulted in increased p21 and
p27 expression and cell cycle arrest, whereas reduced CTCF in
mouse oocytes induced meiotic and mitotic defects and apoptotic cell death before the blastocyst stage (Fedoriw et al., 2004;
Heath et al., 2008; Wan et al., 2008). Deletion of Ctcf in the
developing limb bud resulted in massive apoptosis and nearcomplete loss of limb structures, accompanied by increased p53
upregulated modulator of apoptosis (PUMA), a known activator
of caspase-mediated apoptosis (Nakano and Vousden, 2001; Yu
et al., 2001; Soshnikova et al., 2010). In human cancer cells, CTCF
binds to the Puma gene, and its depletion results in increased
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Table 1. Primer sequences used for genotyping, gene expression, and qChIP
analyses
Primer Name

Forward sequence (5⬘-3⬘)

Reverse sequence (5⬘-3⬘)

Ctcf
NestinCre
Sry
Puma genotyping WT
Puma genotyping KO
Ctcf expression
Puma expression
␤-actin expression
5⬘ 5 kb Puma CBS
Puma CBS1
Puma CBS2
3⬘ 5 kb Puma CBS
5⬘ 1 kb p53BS
Puma p53BS
3⬘ 1 kb p53BS

CTAGGAGTGTAGTTCAGTGAGGCC
TGACCAGAGTCATCCTTAGCG
GCAGGTGGAAAAGCCTTACA
AGGCTGTCCCTGCGGTCATCC
AGGCTGTCCCTGCGGTCATCC
CGATATGCTCTCATCCAGCA
CGTGTGGAGGAGGAGGAGT
CTGTCGAGTCGCGTCCACCC
ACCCTCGTGTTTGGAGTGAC
GCTCCTCCCAGGTCTCACTA
AGGAATGGATCTGCTGGATG
GAGCCCCTGCCTAGTAGGAT
AAAAATGGGCTTGGAGAGC
CTGTCCCCACGCTGC
AGCCAGGGCTACACAGAGAA

GCTCTAAAGAAGGTTGTGAGTTC
AATGCTTCTGTCCGTTTGCC
AAGCTTTGCTGGTTTTTGGA
GGACTGTCGCGGGCTAGACCCTCTA
ACCGCGGGCTCCGAGTAGC
TCCCACACTTGGAACAGACA
GGAGGAGTCCCATGAAGAGA
ACATGCCGGAGCCGTTGTCG
CTCCTGCCTTGTGCCTAAAG
CAGCTTTCATCACTGGGACT
GTTGCTGACTCACCGGCTAT
TAGTCCCTGTGTGTGCTTGC
CCACCACTGTCCAGCTTGTT
GCTTGCTTGCTGGTGTCG
CTGAGCCATCTCTCCAGTCC

KO, Knock-out; WT, wild type.

Puma transcript and rapid apoptosis, indicating that Puma transcription can be directly influenced by the presence or absence of
CTCF (Gomes and Espinosa, 2010a,b).
Given the deleterious effects of CTCF mutations in the human
CNS, we specifically inactivated Ctcf in the developing mouse
brain. CTCF loss of function using two different Cre driver lines
in mice triggered apoptosis in dividing neuroprogenitor cells
(NPCs) of the forebrain. Despite prevention of apoptosis by
Puma deletion, rescued Ctcf/Puma double-null apical and outer
radial glia (oRG) progenitors exhibited decreased proliferative
capacity. Furthermore, loss of CTCF caused premature neurogenesis, resulting in depletion of the progenitor pool and a microcephaly phenotype at birth. These findings highlight the
complexity of CTCF activities during neurogenesis.

Materials and Methods
Mouse husbandry and genotyping. Mice were exposed to 12 h light/dark
cycles and fed tap water and regular chow ad libitum. The Ctcf loxP mice,
in which loxP sites flank exons 3–12, have been described previously
(Heath et al., 2008). Mice conditionally deficient in CTCF were generated
by crossing Ctcf loxP/⫹ females (C57BL/6 background) with heterozygous
Foxg1Cre knock-in male mice (129/sv background) or with NestinCre
heterozygous male mice (C57BL/6 background; Hébert and McConnell,
2000; Bérubé et al., 2005). To account for decreased Foxg1 expression due
to knock-in of the Cre recombinase gene, Cre ⫹ males were used as controls (Ctcf ⫹/⫹Foxg1-cre⫹/⫺) unless stated otherwise. Using the NestinCre
driver line, Ctcf loxP/loxP mice were crossed with Ctcf loxP/⫹;Nestin⫹ mice
to generate Ctcf lox/P/loxP or Ctcf loxP/⫹ (controls) and Ctcf loxP/loxP;Nestin⫹
(Ctcf Nes-cre). Puma⫺/⫺ (Bbc3tm1Ast) mice were obtained from The Jackson Laboratory (stock #011067; Villunger et al., 2003). DNA from tail
biopsies of newborn pups or yolk sac from embryos was genotyped by
PCR. Primer sequences are provided in Table 1.
Immunostaining and histology. For immunofluorescence staining,
cryosections were incubated with the primary antibody overnight at 4°C,
washed in PBS/0.3% Triton-X 100, and incubated with the secondary
antibody for 1 h. Sections were counterstained with DAPI (SigmaAldrich) and mounted in SlowFade Gold (Invitrogen). Primary antibodies used were as follows: rabbit anti-CTCF (1:400; Cell Signaling
Technology), rabbit anti-cleaved caspase 3 (AC3; Asp175; 1:400; Cell
Signaling Technology), mouse anti-BrdU (1:50; BD Biosciences), rabbit
anti-PUMA (1:200; Cell Signaling Technology), rabbit anti-TBR2 (1:200;
Abcam), goat anti-SOX2 (1:400; Santa Cruz Biotechnology), goat antiPAX6 (1:200; Santa Cruz Biotechnology), rabbit anti-SOX2 (1:100; Millipore Bioscience Research Reagents), rabbit anti-Ki67 (1:200; Abcam),
rabbit anti-TBR1 (1:200; Abcam), mouse anti-SATB2 (1:200; Abcam),
and rabbit anti-CTIP2 (1:200; Abcam). Secondary antibodies used were
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as follows: goat-anti-rabbit Alexa 594 (1:800; Invitrogen), goat-antimouse Alexa 488 (1:800; Invitrogen), donkey-anti-sheep Alexa 594 (1:
800; Invitrogen), and donkey-anti-mouse Alexa 488 (1:800; Invitrogen).
Sections were subjected to antigen retrieval (incubated in 0.1 mM sodium
citrate, pH 6.0, heated to ⬃95°C and microwaved on low for 10 min)
before overnight incubation (for BrdU, SOX2, PAX6, TBR2, STAB2,
TBR1, and CTIP2). Terminal deoxynucleotidyl nick end labeling
(TUNEL) was performed according to the manufacturer’s instructions
(Roche). For histological studies, slides were stained with hematoxylin
and eosin (H&E).
BrdU labeling. Pregnant mice were injected intraperitoneally with cell
proliferation labeling reagent [10 mM bromodeoxyuridine (BrdU) and 1
mM fluorodeoxyuridine (FdU) in H2O] at 1 ml/100 g body weight, or 0.3
mg/g body weight (GE Healthcare Life Sciences). Animals were killed
after 1 h by CO2 asphyxiation, and the embryos were recovered in icecold PBS, pH 7.4, and were fixed in 4% paraformaldehyde. Tissue was
equilibrated in 30% sucrose/PBS and frozen in OCT (Tissue Tek). For
cell cycle exit analysis, pregnant female mice (E13) were injected with cell
proliferation labeling reagent at 1 ml/100 g body weight (GE Healthcare
Life Sciences), and embryos were collected and processed for immunofluorescence analysis 24 h later. Before immunofluorescence analysis,
cryosections (8 m) were treated with 2N HCl to denature the DNA, and
neutralized with 0.1 M Na2B4O7, pH 8.5.
Primary NPC cultures and manipulation. Cortical progenitor cultures
were prepared as described previously (Slack et al., 1998; Gloster et al.,
1999; Watson et al., 2013) using cortices dissected from E12.5 embryos.
Cells were seeded on polyornithine-coated (Sigma-Aldrich) plastic plates
or glass coverslips. Cells were fixed in 4% paraformaldehyde for 10 min,
washed in PBS, and processed for immunofluorescence. Cell viability was
measured using the trypan blue dye exclusion method. Cell counts were
determined with a hemacytometer.
Western blot analysis. Nuclear protein was extracted from the E16.5
telencephalon using a standard extraction kit (Thermo Scientific) and
quantified using the Bradford assay. Protein (20 g) was resolved on a
6% SDS-polyacrylamide gel and transferred onto a nitrocellulose membrane (Bio-Rad). The membrane was probed with rabbit anti-p53 (1:500;
Santa Cruz Biotechnology) and rabbit anti-inner centromere protein
(INCENP) (1:10000; Sigma Aldrich) antibodies followed by the appropriate horseradish peroxidase-conjugated secondary antibodies (1:4000;
GE Healthcare Life Sciences). The membrane was incubated in ECL before exposure to x-ray film. Densitometry analysis was performed using
ImageJ software (version 1.47).
Real-time PCR. Total RNA was isolated using the RNeasy Mini kit
(Qiagen). First-strand cDNA was synthesized from 1 g of total RNA
using the SuperScriptTM II Reverse Transcriptase kit (Invitrogen) with
deoxyribonucleotide triphosphates (dNTPs) (1 mM final concentration;
GE Healthcare), porcine RNAguard (GE Healthcare), and 0.3 g random primers (GE Healthcare). Amplification was performed using a
Chromo-4 Continuous Fluorescence Detector (Bio-Rad) in the presence of
iQ SYBR Green supermix (Bio-Rad) and recorded using Opticon Monitor 3
software (Bio-Rad). Results were normalized to ␤-actin expression, and relative gene expression levels were calculated using GeneX software (Bio-Rad).
Samples were amplified as follows: 95°C for 10 s, annealed for 20 s, 72°C for
30 s. After amplification, a melting curve was generated, and samples were
resolved on a 1.5% agarose gel (75 V for 1 h) to verify amplicon purity.
Primer oligomers were designed using Primer3 software (http://bioinfo.ut.
ee/primer3-0.4.0/primer3/) and were obtained from Integrated DNA Technologies. Sequences are provided in Table 1.
Chromatin immunoprecipitation. Chromatin immunoprecipitation
(ChIP) experiments were performed as described previously (Kernohan
et al., 2010). Briefly, mouse forebrain tissue was dissected and processed
to single-cell suspension. Cells were cross-linked in 1% formaldehyde,
lysed in SDS buffer and sonicated. Immunoprecipitation was performed
with a rabbit anti-CTCF antibody (Cell Signaling Technology) and a
rabbit anti-p53 antibody (Santa Cruz Biotechnology). Input samples
represent 1/25 of total chromatin input. ChIP products were amplified in
duplicate with iQ SYBR Green Master Mix (Bio-Rad) on a Chromo-4
thermocycler under the following conditions: 95°C for 5 min, followed
by 35 cycles of 95°C for 10 s, 55°C for 20 s, 72°C for 30 s, and a final
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Figure 1. Foxg1Cre-mediated deletion of Ctcf results in a massive increase in apoptosis. A, Table of genotypes obtained during the embryonic and postnatal periods. Ratios at each time point were
analyzed using a  2 test. Het, Ctcf flox/WT;Foxg1-cre⫹/⫺. B, Dark-field images of control and Ctcf Foxg1-cre embryos at E13.5. (Please note limbs were taken for genotyping). C, H&E staining of E13.5
sagittal cryosections demonstrates complete loss of cortex (Ctx), hippocampal hem (H), basal ganglia (BG), lens (L), and anterior retina (AR), but not the posterior retina (PR), in Ctcf Foxg1-cre embryos.
D, Dark-field images of control and Ctcf Foxg1-cre embryos at E11.5. The dashed circle outlines the telencephalon, which is visibly reduced in size in the Ctcf Foxg1-cre embryos compared to littermate
controls. E, Immunodetection of CTCF (red) in E11.5 sagittal cryosections confirms specific loss of CTCF expression in the forebrain neuroepithelium of Ctcf Foxg1-cre embryos. F, Pregnant females were
subjected to a 1 h BrdU pulse before being killed. Immunodetection of BrdU in E11.5 control and Ctcf Foxg1-cre cortical neuroepithelium is shown. G, BrdU ⫹ cells were counted and expressed as a
percentage of the total number of DAPI ⫹ cells (n ⫽ 3). H, Immunodetection of activated caspase-3 (red) in control and Ctcf Foxg1-cre cortical neuroepithelium at E11.5. I, AC3 ⫹ cells were counted
and expressed as a percentage of the total number of DAPI ⫹ cells (n ⫽ 3). J, TUNEL (green) detection in E11.5 control and Ctcf Foxg1-cre cortical neuroepithelium. Error bars represent the SEM.
Original magnification: C, 25⫻; E, 50⫻; F, H, J, 200⫻. Scale bars: C, top, 1 mm; bottom, 400 m; E, 200 m; F, H, 50 m; J, 100 m.
melting curve generated from 55°C to 95°C in increments of 1°C per plate
read. Fold change and percent input formulas were adapted from (Mukhopadhyay et al., 2008) as follows: percent input ⫽ 100 * [2(⌬CtInput ⫺
⌬CtInput) ⫺ (⌬CtInput ⫺ ⌬CtAb)]/25. Error bars represent the SEM.
Primer sequences are provided in Table 1.
Microscopy. Images were captured with a digital camera (ORCA-ER;
Hamamatsu) using an inverted microscope (DMI 6000b; Leica). Openlab imaging software (PerkinElmer) was used for manual image capture,
and processing was performed using Volocity software (PerkinElmer).
For quantification of AC3 ⫹ cells per area, AC3 ⫹ cells were counted in a
defined area in at least six serial cortical cryosections, and the ratio of
AC3 ⫹ cells to area (square millimeters) was calculated. For BrdU, SOX2,
TBR2, BrdU/Ki67, TBR1, SATB2, and CTIP2 quantification, at least two
serial cortical cryosections were assessed for positive cells within the indicated regions per embryo. DAPI morphology was used to bin cortex
into the ventricular/subventricular zone (VZ/SVZ), intermediate zone
(IZ), and cortical plate (CP).
Statistical analyses. Statistical analysis was performed using GraphPad
Prism software (GraphPad Software; version 4.02), and all results are
expressed as the mean ⫾ SEM. Unless indicated otherwise, p values were
generated using Student’s t test (unpaired, two-tailed) to compare be-

tween two independent data sets. Genotype ratios (Figs. 1A, 2A) were
compared using a  2 test. To compare cell viability data (see Fig. 4E), a
one-way ANOVA was used with Dunnett’s multiple comparison posttest to compare the cell viability of each genotype (Ctcf Nes-cre, Ctcf Nes-cre;
Puma⫺/⫺, and Puma⫺/⫺) to control.
Study approval. All procedures involving animals were conducted in
accordance with the regulations of the Animals for Research Act of the
Province of Ontario and approved by the University of Western Ontario
Animal Care and Use Committee.

Results
Ctcf Foxg1-cre mice exhibit widespread apoptosis and profound
loss of telencephalic and anterior retinal tissue
To study the function of CTCF in the embryonic brain, Ctcf
floxed mice were intercrossed with the previously characterized
Foxg1Cre mice (Hébert and McConnell, 2000; Bérubé et al., 2005;
Heath et al., 2008). Foxg1 expression is first detected between E8
and E9 in the telencephalic neuroepithelium, the basal ganglia,
the olfactory bulbs, and the anterior retina (Dou et al., 1999).
Foxg1-cre⫹ Ctcf loxP/loxP progeny resulting from this cross are Ctcf
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diminished in mutant embryos (Fig. 1 B, C). At E11.5, the telencephalon of mutant embryos was already noticeably smaller
compared to littermate-matched controls (Fig. 1D, hatched circle). CTCF immunostaining demonstrated nuclear expression of
the protein throughout the forebrain in control tissue and its
absence in mutant embryos (Fig. 1E). To determine the underlying cause of cell loss, we measured levels of proliferation and cell
death in E11.5 Ctcf Foxg1-cre and control embryos. Acute (1 h)
BrdU labeling of control and Ctcf Foxg1-cre embryos revealed that
the percentage of cells in S phase does not vary significantly between mutant and control forebrain tissue (Fig. 1 F, G). To measure apoptosis, we stained sections with an antibody against
activated caspase-3 as a marker of cell death (Fig. 1H ). Quantification of the results revealed a large increase in the proportion of
cells undergoing apoptotic cell death in Ctcf Foxg1-cre embryos
compared to littermate-matched controls (Fig. 1I ). TUNEL also
showed increased apoptosis in Ctcf Foxg1-cre embryos compared to
control (Fig. 1J ). Since we already observed profound cell loss by
E11.5, we wanted to analyze whether a similar mechanism was
occurring earlier in this system. We observed increased AC3 immunostaining in Ctcf Foxg1-cre forebrain cryosections at E10.5,
confirming that cell death occurs at this earlier time point (data
not shown). We conclude that deletion of Ctcf in the mouse
forebrain at approximately E8.5 causes extensive apoptosis resulting in profound loss of telencephalic and anterior retinal tissue by E13.5.

Figure 2. NestinCre-mediated deletion of CTCF results in activation of caspase-mediated
apoptosis. A, Table of genotype ratios obtained during the embryonic period. Ratios at each
time point were analyzed by a  2 test. B, Immunodetection of CTCF in E12.5 control and
Ctcf Nes-cre coronal forebrain sections. C, Immunodetection of CTCF in E14 control and Ctcf Nes-cre
coronal forebrain sections. D, Quantification of AC3 immunostaining in E12.5, E14, and E15.5
forebrain tissue (n ⫽ 3). AC3 ⫹ cells were counted and expressed per unit area (square millimeter). E, Immunodetection of AC3 in E15.5 control and Ctcf Nes-cre basal ganglia. F, Immunodetection of AC3 in control and Ctcf Nes-cre at 4 DIV. Het, Ctcf flox/WT;Nestin-cre; Ctx, cortex; BG,
basal ganglia; H, hippocampal hem. Error bars represent the SEM. Original magnification: B, C,
50⫻; D, 100⫻; E, 200⫻. Scale bars: B, 220 m; C, 300 m; E, 100 m; F, 25 m.

null in the anterior retina and forebrain, and will be referred to as
Ctcf Foxg1-cre throughout this text.
We failed to recover live Ctcf Foxg1-cre pups at birth (Fig. 1A). At
E13.5, the size of telencephalic and retinal structures was greatly

NestinCre-driven inactivation of Ctcf decreases cell survival
To determine the outcome of Ctcf deletion at a later embryonic
time point in the telencephalon, we mated Ctcf flox/flox mice to the
previously characterized NestinCre transgenic mice (Bérubé et
al., 2005; Heath et al. 2008). The resulting mutant is hereafter
referred to as Ctcf Nes-cre for simplicity. Cre is expressed after preplate formation in this system, resulting in specific deletion of
Ctcf in neural progenitor cells at approximately E11 (Bérubé et
al., 2005). We obtained the expected ratio of Ctcf Nes-cre mice at
birth; however, almost all mutant pups were already dead and
blue in color (Fig. 2A). One live Ctcf Nes-cre pup was found struggling to breathe, appeared weak, and was killed. We conclude that
neonatal lethality of Ctcf Nes-cre mice is likely due to asphyxiation
at birth.
We first established that the CTCF protein was lost in the basal
ganglia and many cells of the cortex at E12.5 (Fig. 2B), and expression was undetectable in the E14 Ctcf Nes-cre cortex, basal ganglia, and hippocampal hem (Fig. 2C). To determine whether
NestinCre-mediated deletion of Ctcf also induces apoptosis, we
analyzed Ctcf Nes-cre forebrain cryosections at E12.5–E15.5 for evidence of AC3. At E12.5, we observed no increase in apoptotic
cells in the mutant telencephalon (Fig. 2D). However, at E14, we
detected an increase in AC3 ⫹ cells in the Ctcf Nes-cre cortex, basal
ganglia, and hippocampal hem compared to controls (Fig. 2D).
The increase in caspase activation was also observed at E15.5 in all
three forebrain regions, with the highest level of AC3 ⫹ cells in the
basal ganglia (Fig. 2 D, E). Increased apoptotic cell death was also
observed in vitro in primary cortical progenitor cultures established from E12.5 control and Ctcf-null telencephalon. Levels of
AC3 staining were low in both control and Ctcf-null NPCs after
2 d in vitro (DIV), and we only observed a detectable increase in
staining at 4 DIV (Fig. 2F ). Together, the data suggest that when
using the NestinCre driver line of mice, Ctcf deficiency does
trigger the activation of caspase-mediated apoptosis in NPCs,
but the effect is delayed and less severe than that observed in
the Ctcf Foxg1-cre embryos, suggesting that early neuroepithelial
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Figure 3. Loss of CTCF causes p53-dependent transcriptional activation of Puma. A, Western blot analysis of nuclear protein extracts obtained from E16.5 control and Ctcf Nes-cre telencephalon.
Densitometry analysis of blots revealed a 2.3-fold increase in Ctcf Nes-cre p53 levels compared to control. B, C, INCENP was used as a loading control. Immunodetection of PUMA in E11.5 control and
Ctcf Foxg1-cre cortical neuroepithelium (B), E15.5 control and Ctcf Nes-cre forebrain (C), and control and Ctcf-null NPCs (D) at 4 DIV. E, Quantitative real-time PCR analysis of Ctcf and Puma expression in
control and Ctcf Nes-cre E16.5 forebrain using primers spanning Puma exons 3– 4 (n ⫽ 3). ␤-actin was used as an internal control. F, Schematic representation of the mouse Puma gene. PCR products
used to detect sites of CTCF binding (CBS1 and CBS2) and p53 binding (p53BS) are shown. G, Quantitative chromatin immunoprecipitation of CTCF at the Puma gene in E16.5 control and Ctcf Nes-cre
telencephalon tissue (n ⫽ 3). Primer pairs 5 kb upstream and downstream of binding sites were used as negative controls. H, Quantitative chromatin immunoprecipitation of p53 at the Puma gene
in E16.5 control and Ctcf Nes-cre telencephalon tissue shows increased p53 occupancy at the Puma promoter in the Ctcf Nes-cre telencephalon (n ⫽ 3). Primer pairs 1 kb upstream and downstream of
the binding site were used as negative controls. Error bars represent SEM. Original magnification: A, C, 200⫻; B, 100⫻. Scale bars: B, C, 50 m; D, 25 m.

cells are more sensitive to CTCF loss than the neuroprogenitors present slightly later in development.
Increased p53 and PUMA levels in the Ctcf-null telencephalon
Both the Foxg1Cre and NestinCre models of CTCF loss exhibit
increased levels of apoptosis, although the timing of onset differs
between the two mutants. To investigate the molecular mechanism responsible for neuronal cell death due to CTCF loss, we
assessed activation of the p53/PUMA pathway. Using Western
blot analysis, we found that neuronal cell death correlated with an
increase in p53 protein levels in the Ctcf Nes-cre forebrain compared to control, suggesting activation and stabilization of the
protein (Fig. 3A). We next investigated the levels of PUMA,
which has been demonstrated previously to mediate NPC death
downstream of p53 (Jeffers et al., 2003). Moreover, Puma is one
of the most upregulated genes in response to CTCF loss in the
limb bud (Soshnikova et al., 2010). CTCF binding sites in the
Puma gene demarcate an intragenic chromatin boundary that is
abolished upon CTCF knockdown in human cells, resulting in
increased PUMA expression (Gomes and Espinosa, 2010b). To
determine whether PUMA is involved caspase-mediated cell
death in the Ctcf mutant embryos, we examined PUMA protein
levels in the Ctcf Foxg1-cre and Ctcf Nes-cre mice. In the E11.5 Ctcf Foxg1-cre
forebrain, we observed an increase in PUMA immunostaining
compared to littermate controls, corresponding to the high levels
of AC3 staining in these embryos (Fig. 3B). In the Ctcf Nes-cre embryos, PUMA was increased in the E15.5 basal ganglia, again
correlating with the highest levels of cell death (Fig. 3C). In primary cultures, Ctcf-null NPCs exhibited increased PUMA immunostaining at 4 DIV when compared to control NPCs obtained
from littermate embryos (Fig. 3D). We also quantified Puma
transcript levels by quantitative reverse-transcriptase PCR and
observed a significant increase in the E16.5 Ctcf Nes-cre forebrain

compared to controls (Fig. 3E). These observations demonstrate
that increased PUMA transcript and proteins levels occur as a
consequence of CTCF loss in NPCs and correlate with p53 activation and the onset of caspase-mediated cell death.
PUMA upregulation in the Ctcf-deficient embryonic brain
could result from decreased CTCF occupancy within the Puma
gene body, or because of p53-dependent activation of the gene.
To investigate these possibilities further, we performed quantitative CTCF and p53 ChIP using E16.5 telencephalon isolated from
control and Ctcf Nes-cre embryos (Fig. 3F--H ). ChIP analysis confirmed CTCF binding sites found downstream of Puma exon 1
(CBS1) and exon 3 (CBS2) at the Puma gene in control tissue,
similar to the binding profile of CTCF in human cancer cells (Fig.
3G; Gomes and Espinosa, 2010a). As expected, CTCF binding
was diminished in the Ctcf Nes-cre tissue (Fig. 3G). ChIP for p53
demonstrated specific enrichment of the protein at the Puma
promoter in Ctcf Nes-cre forebrain compared to control in E16.5
tissue (Fig. 3H ). Together, loss of CTCF in NPCs causes increased
Puma transcription and protein levels due to increased p53dependent transcriptional activation, likely combined with the
loss of CTCF-dependent repression.
Deletion of Puma in a Ctcf-null context rescues cell death, but
does not improve viability or brain defects at birth
To investigate whether increased PUMA levels cause cell death in
the Ctcf-deficient embryonic brain, we introduced a mutant
Puma allele (Bbc3tm1Ast) in the Ctcf loxP and NestinCre mice to
generate mice that lack both Ctcf and Puma expression in the
brain (hereafter referred to as Ctcf Nes-cre;Puma⫺/⫺). Histological
analysis of E16.5 Ctcf Nes-cre cryosections showed thinning of the
VZ/SVZ, hypocellularity of the intermediate zone, and a dramatic reduction in the size of the hippocampal hem (Fig. 4A).
Ctcf Nes-cre;Puma⫺/⫺ embryos at E16.5 showed rescue in the VZ/
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cell death. The number of cells in the ventricular/subventricular zone is only partially restored, suggesting that loss of cells
cannot completely be explained by increased cell death.
To further confirm that cell viability is
rescued by deletion of Puma in a Ctcf-null
context, we established primary cortical
progenitor cultures from E12.5 control,
Ctcf Nes-cre, Ctcf Nes-cre;Puma⫺/⫺, and Puma⫺/⫺
telencephalon and measured viability via
trypan blue dye exclusion at 2–5 DIV.
Each time point was analyzed by a oneway ANOVA followed by Dunnett’s multiple comparisons post-test to determine
which genotypes had a mean percentage
of viability that was significantly different
from control. No difference in viability
was observed at 2 and 3 DIV; however, at 4
and 5 DIV, Ctcf Nes-cre NPCs exhibited a
marked reduction in viability, correlating
with increased levels of AC3 (Fig. 4E).
NPCs obtained from Ctcf Nes-cre;Puma⫺/⫺
embryos did not show a significant decrease in viability at any of the time points
analyzed (Fig. 4E).
Since we observed a rescue in caspasemediated cell death in the embryonic
Ctcf Nes-cre;Puma⫺/⫺ brain, we predicted
that the brain size at birth would also be
Figure 4. Apoptosis is abolished upon deletion of PUMA in the Ctcf-deficient embryonic brain. A, H&E staining of E16.5 control,
recovered and that the mice would survive
Nes-cre
Nes-cre
⫺/⫺
Nes-cre
Ctcf
, and Ctcf
;Puma
coronal cortical cryosections. Skin and skull cap were not dissected from Ctcf
brain. B,
AC3 immunostaining in E16.5 control, Ctcf Nes-cre, and Ctcf Nes-cre;Puma⫺/⫺ neocortex. C, DAPI ⫹ cells were quantified in 200-m- into the postnatal period, allowing for
wide regions of the control, Ctcf Nes-cre (conditional knock-out), and Ctcf Nes-cre;Puma⫺/⫺ (double knock-out) CP, IZ, and VZ/SVZ more extended analyses. Surprisingly, we
Nes-cre
;Puma⫺/⫺
(n ⫽ 3). D, AC3 ⫹ cells were quantified per unit area in the cortex (Ctx), basal ganglia (BG), and hippocampal hem (H; n ⫽ 3). E, failed to recover live Ctcf
mice
at
birth.
Histological
staining
of
Cell viability of NPC cultures was measured by trypan blue dye exclusion after 2–5 DIV (n ⫽ 3). Data were analyzed by a one-way
ANOVA followed by Dunnett’s multiple comparisons test to determine which means were significantly different from the control. postnatal day 0.5 (P0.5) Ctcf Nes-cre;PuNo significant difference in cell viability was found at 2 and 3 DIV ( p ⫽ 0.2122 and 0.2062, respectively); however, viability was ma⫺/⫺ sections demonstrated severe hysignificantly different between Ctcf Nes-cre and control at 3 and 4 DIV ( p ⬍ 0.01), but not between Ctcf Nes-cre;Puma⫺/⫺ and control pocellularity and disorganization of the
or Puma⫺/⫺ and control ( p ⬎ 0.05). Error bars represent SEM. Original magnification: A, 100⫻; C, 50⫻. Scale bars: A, 200 m; cortical plate and hippocampus, and an
B, 100 m.
overall similarity to the Ctcf Nes-cre neonatal brain (Fig. 5A). Histological cell counts
SVZ thickness, as well as hippocampal size (Fig. 4A). We conconfirmed that there are fewer cells in Ctcf Nes-cre and Ctcf Nes-cre;
firmed these observations by partitioning the E16.5 cortex into
Puma⫺/⫺ cortical plate compared to controls; however, no sigthe CP, IZ, and VZ/SVZ based on cytoarchitecture and quantifynificant difference in cell number was detected between Ctcf Nes-cre
⫹
and Ctcf Nes-cre;Puma⫺/⫺ (Fig. 5B). These findings indicate that
ing the number of DAPI cells per region (Fig. 4 B, C). We observed a restoration in the number of IZ cells and partial
although deletion of Puma prevents Ctcf-null cells from underrestoration in the number of VZ/SVZ cells in the Ctcf Nes-cre;
going apoptosis, other factors come into play to prevent cortical
Puma⫺/⫺ compared to Ctcf Nes-cre cortex (Fig. 4C). There was no
size expansion in the double mutant brain.
significant difference in the number of CP cells between genotypes at E16.5 (Fig. 4C).
Ctcf-null apical and oRG progenitors rescued from death by
We performed AC3 immunostaining in E16.5 brain sections
Puma deletion fail to proliferate
to investigate whether apoptotic cell death was rescued in the
Given that cell death at E16.5 was rescued in the double mutant
double mutant brain. AC3 ⫹ cells were elevated in the Ctcf Nes-cre
embryos but the brain hypocellularity at birth was not, we speccortex, basal ganglia, and hippocampal hem compared to control
ulated that the cells rescued from apoptosis might become ar(Fig. 4 B, D). AC3 ⫹ cells were largely localized to the ventricular
rested in the cell cycle, resulting in decreased proliferation. To test
zone of the neocortex, indicating that Ctcf-null proliferating cells
this hypothesis, we performed acute BrdU labeling at E16.5 and
are more susceptible to caspase-dependent cell death than differquantified the proportion of cells in S phase by BrdU immunoentiated cells of the cortical plate. Deletion of Puma in the Ctcf Nesstaining. To compare the cortical distribution and number of
cre mouse was sufficient to abolish apoptotic cell death, indicating
NPCs in S phase, the E16.5 cortex was partitioned into the CP, IZ,
that PUMA mediates increased caspase-dependent cell death in
and VZ/SVZ based on cytoarchitecture (Fig. 6A). The number
Ctcf-null neuroprogenitor cells (Fig. 4 B, D). Together, these data
of BrdU ⫹ cells was significantly reduced in the Ctcf Nes-cre and
indicate a specific decrease in intermediate zone cellularity in the
Ctcf Nes-cre;Puma⫺/⫺ intermediate zones and ventricular zone/
Nes-cre
E16.5 Ctcf
subventricular zones compared to control (Fig. 6 A, B). Despite
cortex that is fully restored upon inhibition of
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substantial rescue in cellularity of the
Ctcf Nes-cre;Puma ⫺/⫺ cortex compared to
Ctcf Nes- cre at E16.5, the proliferative capacity of progenitors was not significantly
different (Fig. 6 A, B). Our results demonstrate that Puma deletion rescues cell
death in the Ctcf-null brain, but that the
rescued cells display reduced proliferative
capacity.
Three NPC subtypes exist in the embryonic cortex: apical radial glia (apical
progenitors), basal progenitors, and outer
radial glia. Apical progenitors can be identified by their expression of SOX2 and
PAX6 transcription factors (Götz et al.,
1998; Tarabykin et al., 2001; BaniYaghoub et al., 2006; Shitamukai and
Matsuzaki, 2012). They undergo interkinetic nuclear migration and divide at the
ventricular surface to either self-renew or
differentiate into basal progenitors, outer
radial glia, or cortical neurons (Shitamukai et al., 2011; Shitamukai and Matsuzaki, 2012). Basal progenitors reside in the
subventricular zone and uniquely express
the T-box transcription factor TBR2 (Englund et al., 2005). They are reported to
have the potential to self-renew; however,
the majority of their divisions are neurogenic (Haubensak et al., 2004; Miyata et Figure 5. Puma deletion in the Ctcf-deficient brain fails to restore hippocampal size or hypocellularity of the cortical plate. A,
al., 2004; Noctor et al., 2004). Outer radial H&E staining of neonatal (P0.5) control, Ctcf Nes-cre, and Ctcf Nes-cre;Puma⫺/⫺ cortex and hippocampus. Scale bars: top, 800 m;
glia are similar to radial glia in that they bottom, 200 m. Original magnification, 25⫻. B, Graph depicting cortical plate cell counts as a percentage of control (n ⫽ 3).
have a basal process and express SOX2 Error bars represent SEM.
and PAX6; however, oRG cells are located
outside of the VZ in the outer SVZ. They
diminished in the Ctcf Nes-cre cortex compared to control, and was
are able to divide asymmetrically, producing one oRG and one
not restored in the Ctcf Nes-cre;Puma⫺/⫺ cortex (Fig. 8 A, C). Similarly,
neuron-committed cell with each division (Reillo et al., 2011;
BrdU incorporation in the rescued Ctcf Nes-cre;Puma⫺/⫺ oRG cells was
Shitamukai et al., 2011; Wang et al., 2011a,b; Shitamukai and
extremely low, indicating that they are likely arrested in the cell
Matsuzaki, 2012). We performed acute BrdU-labeling for 1 h and
cycle and fail to correctly enter S phase (Fig. 8 A, C). To confirm
coimmunostained E16.5 cortical sections with antibodies against
that these cells are oRG progenitors, we performed SOX2 and
BrdU and TBR2 or SOX2 to examine the behavior of different
PAX6 coimmunostaining and indeed observed a decreased numprogenitor subtypes after loss of CTCF (Figs. 7, 8).
ber of SOX2 ⫹PAX6 ⫹ cells in the intermediate zone of Ctcf Nes-cre
The total number of TBR2 ⫹ basal progenitor cells was reembryos compared to control and Ctcf Nes-cre;Puma⫺/⫺ at E16.5
duced in the Ctcf Nes-cre cortex compared to control (Fig. 7 A, B).
(Fig. 8D).
The number of basal progenitors was restored to control levels in
Ctcf loss causes premature differentiation of apical
the Ctcf Nes-cre;Puma⫺/⫺ cortex, and most rescued cells were still
progenitors
able to enter S phase (Fig. 7 A, C). Despite the correct overall
Incomplete restoration of the apical progenitor population in the
number of TBR2 ⫹ cells in the Ctcf Nes-cre;Puma⫺/⫺ cortex, the
Ctcf Nes-cre;Puma⫺/⫺ cortex suggests that loss of CTCF leads to an
localization of basal progenitors appeared to be shifted apically
apoptosis-independent reduction of these cells (Fig. 8A,B). To idencompared to control (Fig. 7 A, B). This is perhaps due to an inability of the rescued basal progenitors to correctly delaminate
tify the cause of reduced apical cell numbers, we analyzed the profrom the ventricular surface.
genitor pool composition, cell cycle exit indices, and postmitotic
Quantification of SOX2 ⫹ cells indicated a dramatic reduction
projection neuron subtypes in control and Ctcf Nes-cre cortex at E14.
Nes-cre
in the number of apical progenitors and oRGs in the Ctcf
Apical progenitors begin to produce projection neurons at
cortex (Fig. 8 A, B). The number of SOX2 ⫹ apical progenitors was
approximately E11.5. At the same time, they generate neurononly partially rescued in the Ctcf Nes-cre;Puma⫺/⫺ cortex, indicating
committed basal progenitors and oRG progenitors. Since the mathat CTCF may control the size of the apical progenitor pool
jority of basal progenitor divisions are terminal and result in the
independently of apoptosis (Fig. 8 A, B). Conversely, oRG
production of two neurons, this would result in increased gener(SOX2 ⫹ cells in the intermediate zone) numbers were restored to
ation of neurons at the expense of the progenitor pool (Haubencontrol levels in the Ctcf Nes-cre;Puma⫺/⫺ cortex, indicating that
sak et al., 2004; Miyata et al., 2004; Noctor et al., 2004). The
these cells are lost via Puma-mediated apoptotic cell death upon
relative abundance of TBR2 ⫹ basal progenitors was significantly
increased in the E14 Ctcf Nes-cre cortex compared to control,
deletion of Ctcf (Fig. 8 A, B). The proliferative capacity of apical
⫹
⫹
whereas the number of SOX2 ⫹ apical progenitors was not afprogenitors (SOX2 /BrdU cells in the VZ/SVZ) was severely
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Figure 6. Ctcf-deficient cells that are rescued from apoptotic death display reduced proliferative capacity. Pregnant females were subjected to a 1 h BrdU pulse before being killed. A, BrdU (green)
immunostaining of E16.5 control, Ctcf Nes-cre, and Ctcf Nes-cre;Puma⫺/⫺ cortical cryosections. The inset demonstrates fewer BrdU ⫹ cells in the Ctcf Nes-cre and Ctcf Nes-cre;Puma⫺/⫺ IZ compared with
control. Scale bar, 50 m. Original magnification, 100⫻. B, The number of cells in S phase was quantified by counting BrdU ⫹ cells in 200-m-wide cortical images (n ⫽ 3). Error bars represent
SEM.

Figure 7. Ctcf-deficiency results in PUMA-dependent apoptosis of basal progenitor cells. Pregnant females were subjected to a 1 h BrdU pulse before being killed. A, TBR2 (red) and BrdU (green)
coimmunostaining of E16.5 cortical cryosections. Arrowheads indicate TBR2 ⫹/BrdU ⫹ cells in the IZ and VZ/SVZ. Scale bar, 50 m. Original magnification, 100⫻. B, TBR2 ⫹ cells were quantified
in 200-m-wide cortical images (n ⫽ 3). C, TBR2 ⫹/BrdU ⫹ cells were quantified in 200-m-wide cortical images (n ⫽ 3). Error bars represent SEM.

fected (Fig. 9 A, B), suggesting that differentiation of apical progenitors into basal progenitors is increased. Next, we measured
the proportion of cells exiting the cell cycle by labeling embryos
with BrdU for 24 h and analyzing Ki67 ⫹ and BrdU ⫹ cells in E14
control and Ctcf Nes-cre cortex. Cell cycle exit (BrdU ⫹Ki67 ⫺ cells/
total BrdU ⫹ cells) was significantly higher in Ctcf Nes-cre cortex
compared to controls (Fig. 9C,D).
The cortical plate is established by projection neurons that
organize themselves in an “inside-out” manner, such that earlyborn neurons populate deeper cortical layers (layer VI, then layer
V), and late-born neurons migrate past the early-born neurons to
populate the more superficial layers of the cortex (layer IV, then
layer II/III; Greig et al., 2013). Increased cell cycle exit and differentiation at E13–E14 is predicted to result in an increased number of layer VI corticothalamic projection neurons (TBR1 ⫹),
layer V subcerebral projection neurons (CTIP2 ⫹), and callosal
projection neurons (SATB2 ⫹). We found that the relative generation of these neuronal subtypes was increased in the Ctcf Nes-cre
cortex compared to control (Fig. 8E--G), confirming premature
differentiation of Ctcf-null apical progenitors, which is predicted
to result in a reduced number of this progenitor pool by late
neurogenesis.

Discussion
This study provides evidence that CTCF is required at very early
stages of telencephalon development for the maintenance and

survival of neuroprogenitor cells. We found that ablation of
CTCF leads to Puma-dependent apoptosis of NPCs using two
different conditional deletion strategies. Increased apoptosis correlated with p53-dependent Puma transcription, suggesting that
CTCF loss results in p53 stabilization and transcriptional activation of its downstream targets. CTCF loss might also result in a
more open chromatin environment at the Puma gene, facilitating
p53-dependent activation of transcription and elongation of
RNA polymerase II (Gomes and Espinosa, 2010a,b). Ctcf inactivation in postmitotic cortical and hippocampal neurons does not
induce apoptosis (Hirayama et al., 2012), pointing to a specific
survival role for CTCF in proliferating cells. However, CTCF loss
of function may not induce apoptosis in all types of proliferating
cells in vivo, as Ctcf deletion in thymocytes was shown previously
to induce cell cycle arrest without induction of apoptosis (Heath
et al., 2008). It is possible that the outcome of CTCF deficiency
leads to either p53-dependent cell cycle arrest or apoptosis, depending on varying cell-specific or temporal cues. This could be
similar to the outcomes described upon Nbs1 (Nijmegen breakage
syndrome 1/Nibrin) deletion in the CNS, which leads to p53dependent apoptosis in the cerebellum, but causes p53dependent cell cycle arrest in the neocortex (Li et al., 2012).
In the present report, we demonstrate that deletion of Puma
effectively rescues apoptotic cell death observed at E16.5 in the
Ctcf Nes-cre brain (Fig. 4). Despite this apparent recovery at E16.5,
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Figure 8. Ctcf-deficiency results in PUMA-dependent apoptosis of apical and outer radial glia progenitors. Apical and outer radial glia progenitors that are rescued from apoptotic death fail to
proliferate. Pregnant females were subjected to a 1 h BrdU pulse before being killed. A, SOX2 (red) and BrdU (green) coimmunostaining of E16.5 cortical cryosections. The inset demonstrates fewer
SOX2 ⫹ cells in the Ctcf Nes-cre IZ than control or Ctcf Nes-cre;Puma⫺/⫺. B, SOX2 ⫹ cells were quantified in 200-m-wide cortical images (n ⫽ 3). C, SOX2 ⫹/BrdU ⫹ cells were quantified in
200-m-wide cortical images (n ⫽ 3). D, Immunodetection of SOX2 (green) and PAX6 (red) in the E16.5 cortical IZ demonstrates restoration of oRG progenitors in Ctcf Nes-cre;Puma⫺/⫺ cortex
compared to Ctcf Nes-cre. Arrowheads indicate SOX2 ⫹/PAX6 ⫹ oRG cells. Error bars represent SEM. Original magnification: A, D, 100⫻. Scale bars: A, 50 m; D, 10 m.

Figure 9. Ctcf-deficiency causes premature neurogenesis. A, Immunodetection of SOX2 (red) and TBR2 (green) in E14 control and Ctcf Nes-cre cortex. B, SOX2 ⫹, TBR2 ⫹, and SOX2 ⫹/TBR2 ⫹ cells
were quantified in 150-m-wide cortical images and expressed as a percentage of total DAPI ⫹ cells (n ⫽ 3). C, Pregnant female mice were subjected to a 24 h BrdU pulse before being killed. Ki67
(red) and BrdU (green) immunostaining was used to determine the percentage of cells exiting the cell cycle in control and Ctcf Nes-cre E14 cortex. Arrowheads indicate BrdU ⫹Ki67 ⫺ cells that have
exited the cell cycle. D, Cell cycle exit indices were calculated by measuring the ratio of BrdU ⫹Ki67 ⫺ cells to total BrdU ⫹ cells in control and Ctcf Nes-cre cortex at E14 (n ⫽ 3). E, Immunodetection
of TBR1 (red) and SATB2 (green) in E14 control and Ctcf Nes-cre cortex. F, Immunodetection of CTIP2 (green) in E14 control and Ctcf Nes-cre cortex. G, SATB2 ⫹, TBR1 ⫹, and CTIP2 ⫹ cells were quantified
and expressed as a percentage of DAPI ⫹ cells (n ⫽ 3). Error bars represent SEM. Original magnification: A, C, E, F, 100⫻. Scale bars: A, C, 50 m; E, F, 50 m.

the double mutant brain at birth appeared hypocellular and was
nearly undistinguishable histologically from the Ctcf Nes-cre brain
(Fig. 5). We showed that Ctcf Nes-cre;Puma⫺/⫺ apical and oRG
progenitors that cannot activate the apoptotic pathway fail to
incorporate BrdU, which might be explained by a p53-mediated
cell cycle arrest. Further investigations into the mechanism underlying increased p53 levels in the Ctcf-null brain will be important to fully elucidate the role of CTCF in progenitor cell survival.

Given that oRG cells are implicated in neocortical expansion in
humans, their reduced ability to proliferate in the double mutant
cortex might partly explain the failure to recover cortical size at
birth, and may be relevant to microcephaly caused by CTCF mutations in humans (Hansen et al., 2010; Lui et al., 2011; Reillo et
al., 2011).
A key observation is that deletion of Puma did not completely
restore the number of apical cells in the Ctcf Nes-cre;Puma⫺/⫺ cor-
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tex, suggesting that while a proportion of this progenitor population undergoes Puma-dependent death in the absence of CTCF,
apical cells exhibit an independent defect. We found that Ctcfnull apical progenitors differentiate prematurely, causing an
initial increase in the production of basal progenitors and earlyborn postmitotic neurons (Fig. 9). However, the increased number of basal progenitors is later counteracted by a reduction of the
progenitor pool from which they are derived, and exacerbated by
increased levels of apoptosis. Given that CTCF colocalizes with
the cohesin complex and is required for cohesin localization to
specific genomic sites to influence gene expression (Parelho et al.,
2008; Wendt et al., 2008), it is conceivable that premature neurogenesis in the Ctcf Nes-cre cortex results from dysregulation of
CTCF target genes.
The number of basal progenitor cells marked by TBR2 expression was completely restored in the double mutant brain, indicating that PUMA activation causes basal progenitor cell death in
the absence of CTCF. Simultaneous labeling of brain sections
with TBR2 and BrdU showed that rescued basal progenitors are
still able to proliferate, unlike rescued apical and oRG cells. Despite the overall equivalent number of TBR2 ⫹ cells in the control
and double mutant cortex, several rescued basal progenitors did
not move basally out of the ventricular zone, perhaps due to a
defect in apical radial glia or an inability to correctly delaminate
from the apical surface of the Ctcf-deficient cortex.
In summary, we demonstrated that CTCF is required in the
early developing mouse brain for neuroprogenitor cell survival
and that its deletion induces p53- and PUMA-dependent apoptosis. Independent from its role in promoting cell survival, CTCF is
required for the correct balance of proliferative versus differentiative divisions and maintenance of the apical progenitor pool.
Together, these functions of CTCF contribute to the normal development of the mammalian neocortex.
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